177 related articles for article (PubMed ID: 32345613)
1. YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition.
Ajani JA; Xu Y; Huo L; Wang R; Li Y; Wang Y; Pizzi MP; Scott A; Harada K; Ma L; Yao X; Jin J; Zhao W; Dong X; Badgwell BD; Shanbhag N; Tatlonghari G; Estrella JS; Roy-Chowdhuri S; Kobayashi M; Vykoukal JV; Hanash SM; Calin GA; Peng G; Lee JS; Johnson RL; Wang Z; Wang L; Song S
Gut; 2021 Jan; 70(1):55-66. PubMed ID: 32345613
[TBL] [Abstract][Full Text] [Related]
2. Patient-derived cell lines and orthotopic mouse model of peritoneal carcinomatosis recapitulate molecular and phenotypic features of human gastric adenocarcinoma.
Song S; Xu Y; Huo L; Zhao S; Wang R; Li Y; Scott AW; Pizzi MP; Wang Y; Fan Y; Harada K; Jin J; Ma L; Yao X; Shanbhag ND; Gan Q; Roy-Chowdhuri S; Badgwell BD; Wang Z; Wang L; Ajani JA
J Exp Clin Cancer Res; 2021 Jun; 40(1):207. PubMed ID: 34162421
[TBL] [Abstract][Full Text] [Related]
3. FGF18-FGFR2 signaling triggers the activation of c-Jun-YAP1 axis to promote carcinogenesis in a subgroup of gastric cancer patients and indicates translational potential.
Zhang J; Wong CC; Leung KT; Wu F; Zhou Y; Tong JHM; Chan RCK; Li H; Wang Y; Yan H; Liu L; Wu WKK; Chan MWY; Cheng ASL; Yu J; Wong N; Lo KW; To KF; Kang W
Oncogene; 2020 Oct; 39(43):6647-6663. PubMed ID: 32934314
[TBL] [Abstract][Full Text] [Related]
4. GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma.
Li Y; Fan Y; Xu J; Huo L; Scott AW; Jin J; Yang B; Shao S; Ma L; Wang Y; Yao X; Pool Pizzi M; Sewastjanow Da Silva M; Zhang G; Zhuo L; Cho EJ; Dalby KN; Shanbhag ND; Wang Z; Li W; Song S; Ajani JA
J Exp Clin Cancer Res; 2022 Aug; 41(1):257. PubMed ID: 35996148
[TBL] [Abstract][Full Text] [Related]
5. YES-associated protein 1 promotes adenocarcinoma growth and metastasis through activation of the receptor tyrosine kinase Axl.
Cui ZL; Han FF; Peng XH; Chen X; Luan CY; Han RC; Xu WG; Guo XJ
Int J Immunopathol Pharmacol; 2012; 25(4):989-1001. PubMed ID: 23298489
[TBL] [Abstract][Full Text] [Related]
6. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.
Wang R; Song S; Harada K; Ghazanfari Amlashi F; Badgwell B; Pizzi MP; Xu Y; Zhao W; Dong X; Jin J; Wang Y; Scott A; Ma L; Huo L; Vicente D; Blum Murphy M; Shanbhag N; Tatlonghari G; Thomas I; Rogers J; Kobayashi M; Vykoukal J; Estrella JS; Roy-Chowdhuri S; Han G; Zhang S; Mao X; Song X; Zhang J; Gu J; Johnson RL; Calin GA; Peng G; Lee JS; Hanash SM; Futreal A; Wang Z; Wang L; Ajani JA
Gut; 2020 Jan; 69(1):18-31. PubMed ID: 31171626
[TBL] [Abstract][Full Text] [Related]
7. Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells.
Giraud J; Molina-Castro S; Seeneevassen L; Sifré E; Izotte J; Tiffon C; Staedel C; Boeuf H; Fernandez S; Barthelemy P; Megraud F; Lehours P; Dubus P; Varon C
Int J Cancer; 2020 Apr; 146(8):2255-2267. PubMed ID: 31489619
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression of Nodal and YAP1 is associated with poor prognosis of gastric adenocarcinoma.
Li P; Sun D; Li X; He Y; Li W; Zhao J; Wang Y; Wang H; Xin Y
J Cancer Res Clin Oncol; 2016 Aug; 142(8):1765-73. PubMed ID: 27325246
[TBL] [Abstract][Full Text] [Related]
9. PPARδ Interacts with the Hippo Coactivator YAP1 to Promote SOX9 Expression and Gastric Cancer Progression.
Song S; Wang Z; Li Y; Ma L; Jin J; Scott AW; Xu Y; Estrella JS; Song Y; Liu B; Johnson RL; Ajani JA
Mol Cancer Res; 2020 Mar; 18(3):390-402. PubMed ID: 31796534
[TBL] [Abstract][Full Text] [Related]
10. Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment.
Fan Y; Li Y; Yao X; Jin J; Scott A; Liu B; Wang S; Huo L; Wang Y; Wang R; Pool Pizzi M; Ma L; Shao S; Sewastjanow-Silva M; Waters R; Chatterjee D; Liu B; Shanbhag N; Peng G; Calin GA; Mazur PK; Hanash SM; Ishizawa J; Hirata Y; Nagano O; Wang Z; Wang L; Xian W; McKeon F; Ajani JA; Song S
Gut; 2023 Apr; 72(4):624-637. PubMed ID: 36002248
[TBL] [Abstract][Full Text] [Related]
11. Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis.
Kang W; Tong JH; Chan AW; Lee TL; Lung RW; Leung PP; So KK; Wu K; Fan D; Yu J; Sung JJ; To KF
Clin Cancer Res; 2011 Apr; 17(8):2130-9. PubMed ID: 21346147
[TBL] [Abstract][Full Text] [Related]
12. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
[TBL] [Abstract][Full Text] [Related]
13. Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma.
Wang R; Dang M; Harada K; Han G; Wang F; Pool Pizzi M; Zhao M; Tatlonghari G; Zhang S; Hao D; Lu Y; Zhao S; Badgwell BD; Blum Murphy M; Shanbhag N; Estrella JS; Roy-Chowdhuri S; Abdelhakeem AAF; Wang Y; Peng G; Hanash S; Calin GA; Song X; Chu Y; Zhang J; Li M; Chen K; Lazar AJ; Futreal A; Song S; Ajani JA; Wang L
Nat Med; 2021 Jan; 27(1):141-151. PubMed ID: 33398161
[TBL] [Abstract][Full Text] [Related]
14. Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma.
Mizrak Kaya D; Nogueras-González GM; Harada K; Amlashi FG; Roy-Chowdhuri S; Estrella JS; Das P; Lee JH; Weston B; Bhutani MS; Matamoros A; Thomas I; Lin Q; Badgwell BD; Ajani JA
J Surg Oncol; 2018 Mar; 117(4):678-684. PubMed ID: 29205363
[TBL] [Abstract][Full Text] [Related]
15. LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma.
Xu Y; Li Y; Jin J; Han G; Sun C; Pizzi MP; Huo L; Scott A; Wang Y; Ma L; Lee JH; Bhutani MS; Weston B; Vellano C; Yang L; Lin C; Kim Y; MacLeod AR; Wang L; Wang Z; Song S; Ajani JA
Mol Cancer; 2019 Oct; 18(1):141. PubMed ID: 31601234
[TBL] [Abstract][Full Text] [Related]
16. A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma.
Song S; Xie M; Scott AW; Jin J; Ma L; Dong X; Skinner HD; Johnson RL; Ding S; Ajani JA
Mol Cancer Ther; 2018 Feb; 17(2):443-454. PubMed ID: 29167315
[TBL] [Abstract][Full Text] [Related]
17. Concurrent Targeting of Potential Cancer Stem Cells Regulating Pathways Sensitizes Lung Adenocarcinoma to Standard Chemotherapy.
Shibata M; Ooki A; Inokawa Y; Sadhukhan P; Ugurlu MT; Izumchenko E; Munari E; Bogina G; Rudin CM; Gabrielson E; Singh A; Hoque MO
Mol Cancer Ther; 2020 Oct; 19(10):2175-2185. PubMed ID: 32847981
[TBL] [Abstract][Full Text] [Related]
18. AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis.
Zhou Y; Zhang J; Li H; Huang T; Wong CC; Wu F; Wu M; Weng N; Liu L; Cheng ASL; Yu J; Wong N; Lo KW; Tang PMK; Kang W; To KF
Oncogene; 2020 May; 39(22):4375-4389. PubMed ID: 32313226
[TBL] [Abstract][Full Text] [Related]
19. The transcription factor RUNX2 fuels YAP1 signaling and gastric cancer tumorigenesis.
Guo Z; Zhou K; Wang Q; Huang Y; Ji J; Peng Y; Zhang X; Zheng T; Zhang Z; Chong D; Yang Z
Cancer Sci; 2021 Sep; 112(9):3533-3544. PubMed ID: 34160112
[TBL] [Abstract][Full Text] [Related]
20. YAP1 and COX2 Coordinately Regulate Urothelial Cancer Stem-like Cells.
Ooki A; Del Carmen Rodriguez Pena M; Marchionni L; Dinalankara W; Begum A; Hahn NM; VandenBussche CJ; Rasheed ZA; Mao S; Netto GJ; Sidransky D; Hoque MO
Cancer Res; 2018 Jan; 78(1):168-181. PubMed ID: 29180467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]